Skip to main content
Novel Method for Treating Steatosis-Associated Diseases

Novel Method for Treating Steatosis-Associated Diseases

Unmet Need Steatosis-associated diseases are marked by the infiltration of the liver with fatty acids. Liver steatosis occurs in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), as well as rare diseases such as…

Read More

Method for immune tolerance induction in patients receiving enzyme replacement therapy for a variety of metabolic disorders

Method for immune tolerance induction in patients receiving enzyme replacement therapy for a variety of metabolic disorders

Unmet Need Genetically based metabolic disorders affect 1 in 2500 births globally and many of these disorders result in an enzyme deficiency. In most cases, a single enzyme is not produced by the body at…

Read More

A method of screening and monitoring glycogen storage diseases with a single biomarker

A method of screening and monitoring glycogen storage diseases with a single biomarker

Unmet Need Glycogen storage disease type I (GSD I) is an autosomal recessive inherited disorder of carbohydrate metabolism associated with life threatening fasting hypoglycemia, and significant morbidity and mortality. Currently, the standard of care therapy…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us